NewsRx

Search our medical news database

Hepatitis C Virus

Researchers' work from Japan, the United States and the United Kingdom adds to hepatitis C virus body of knowledge

Published in Hepatitis Weekly, October 23rd, 2006

Hepatitis c virus data are the focus of recent research from Japan, the United States and the United Kingdom.

Study 1: Recent research from Japan has reported on the identification of defective hepatitis C virus (HCV) clones in liver transplant recipients with recurrent HCV infection.

"Patients with recurrent hepatitis C after liver transplantation usually have a high viral load and are generally resistant to interferon (IFN)-alpha 2b plus ribavirin (RBV) therapy. However, it remains unclear whether pretreatment viral titer determines the effectiveness of combination therapy, especially in patients with a high viral load.

"The aim...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook